VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Although lymphedema is a common clinical condition, treatment for this disabling condition remains limited and largely ineffective. Recently, it has been reported that overexpression of VEGF-C correlates with increased lymphatic vessel growth (lymphangiogenesis). However, the effect of VEGF-C-induce...

Полное описание

Библиографические подробности
Главные авторы: Yoon, Y, Murayama, T, Gravereaux, E, Tkebuchava, T, Silver, M, Curry, C, Wecker, A, Kirchmair, R, Hu, C, Kearney, M, Ashare, A, Jackson, D, Kubo, H, Isner, J, Losordo, D
Формат: Journal article
Язык:English
Опубликовано: 2003

Схожие документы